1. Home
  2. NRSN vs CRWS Comparison

NRSN vs CRWS Comparison

Compare NRSN & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • CRWS
  • Stock Information
  • Founded
  • NRSN 2017
  • CRWS 1957
  • Country
  • NRSN Israel
  • CRWS United States
  • Employees
  • NRSN N/A
  • CRWS N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • CRWS Textiles
  • Sector
  • NRSN Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • NRSN 26.0M
  • CRWS 30.5M
  • IPO Year
  • NRSN 2021
  • CRWS N/A
  • Fundamental
  • Price
  • NRSN $1.18
  • CRWS $2.89
  • Analyst Decision
  • NRSN Buy
  • CRWS
  • Analyst Count
  • NRSN 2
  • CRWS 0
  • Target Price
  • NRSN $14.00
  • CRWS N/A
  • AVG Volume (30 Days)
  • NRSN 1.4M
  • CRWS 45.1K
  • Earning Date
  • NRSN 09-17-2025
  • CRWS 11-11-2025
  • Dividend Yield
  • NRSN N/A
  • CRWS 11.11%
  • EPS Growth
  • NRSN N/A
  • CRWS N/A
  • EPS
  • NRSN N/A
  • CRWS N/A
  • Revenue
  • NRSN N/A
  • CRWS $86,516,000.00
  • Revenue This Year
  • NRSN N/A
  • CRWS N/A
  • Revenue Next Year
  • NRSN N/A
  • CRWS N/A
  • P/E Ratio
  • NRSN N/A
  • CRWS N/A
  • Revenue Growth
  • NRSN N/A
  • CRWS N/A
  • 52 Week Low
  • NRSN $0.80
  • CRWS $2.76
  • 52 Week High
  • NRSN $2.60
  • CRWS $4.96
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 46.42
  • CRWS 39.67
  • Support Level
  • NRSN $1.14
  • CRWS $2.82
  • Resistance Level
  • NRSN $1.28
  • CRWS $3.07
  • Average True Range (ATR)
  • NRSN 0.15
  • CRWS 0.10
  • MACD
  • NRSN 0.03
  • CRWS -0.02
  • Stochastic Oscillator
  • NRSN 22.33
  • CRWS 21.88

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: